Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
December 04 2013 - 10:57AM
Marketwired
Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl
Brand of Nausea Remedy
LAGUNA HILLS, CA--(Marketwired - Dec 4, 2013) - Itonis, Inc.
(PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the
Zicam® cold remedy, are pleased to announce that the Company has
completed packaging graphics for its Emesyl™ Nausea Remedy.
"The Emesyl graphics theme is conservative and yet the packaging
is designed to stand out on the store shelves," says Dr. Charles
Hensley. "Our goal is to have our packaging reflect that Emesyl is
an effective and competitive product that can be used with
confidence."
About Itonis
Pharmaceuticals Itonis Pharmaceuticals, a new division of
Itonis, Inc., is headed by Charles Hensley, Ph.D. This division's
mission is to create and market over-the-counter and prescription
homeopathic products that better people's lives. Dr. Hensley is a
pioneer in the development and marketing of safe and effective
therapeutic nutraceutical and homeopathic preparations. He was
a founder of the company that launched the Zicam® Cold Remedy,
making the product a household name and forever changing the
marketing and product placement paradigm for homeopathic drugs in
the United States. Dr. Hensley and his team plan to use the
same methodologies to revolutionize the treatment of several other
common ailments and other chronic diseases.
About Itonis,
Inc.
Itonis, Inc. was incorporated in the state of Nevada on July 5,
2005 under the name of Kenshou, Inc., which later changed to
Itonis, Inc. on December 2, 2005. Please visit
www.itonisholdings.com.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact: Itonis, Inc. Email Contact
Itonis (PK) (USOTC:ITNS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Itonis (PK) (USOTC:ITNS)
Historical Stock Chart
From Sep 2023 to Sep 2024